Kuangli Bio-Tech Holdings Co (TPE:6431) Debt-to-Equity : 0.45 (As of Mar. 2025)

View and export this data going back to 2014. Start your Free Trial

What is Kuangli Bio-Tech Holdings Co Debt-to-Equity?

Kuangli Bio-Tech Holdings Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2025 was NT$198.4 Mil. Kuangli Bio-Tech Holdings Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2025 was NT$140.1 Mil. Kuangli Bio-Tech Holdings Co's Total Stockholders Equity for the quarter that ended in Mar. 2025 was NT$755.7 Mil. Kuangli Bio-Tech Holdings Co's debt to equity for the quarter that ended in Mar. 2025 was 0.45.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Kuangli Bio-Tech Holdings Co's Debt-to-Equity or its related term are showing as below:

TPE:6431' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.01 Med: 0.52 Max: 0.77
Current: 0.45

During the past 12 years, the highest Debt-to-Equity Ratio of Kuangli Bio-Tech Holdings Co was 0.77. The lowest was 0.01. And the median was 0.52.

TPE:6431's Debt-to-Equity is ranked worse than
64.43% of 2165 companies
in the Hardware industry
Industry Median: 0.28 vs TPE:6431: 0.45

Kuangli Bio-Tech Holdings Co Debt-to-Equity Historical Data

The historical data trend for Kuangli Bio-Tech Holdings Co's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kuangli Bio-Tech Holdings Co Debt-to-Equity Chart

Kuangli Bio-Tech Holdings Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Debt-to-Equity

Get a 7-Day Free Trial

0.02

0.72

0.52

0.76

0.73

Kuangli Bio-Tech Holdings Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Debt-to-Equity	Get a 7-Day Free Trial															0.68	0.75	0.66	0.73	0.45

Competitive Comparison of Kuangli Bio-Tech Holdings Co's Debt-to-Equity

For the Electronic Components subindustry, Kuangli Bio-Tech Holdings Co's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kuangli Bio-Tech Holdings Co's Debt-to-Equity Distribution in the Hardware Industry

For the Hardware industry and Technology sector, Kuangli Bio-Tech Holdings Co's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Kuangli Bio-Tech Holdings Co's Debt-to-Equity falls into.

Save Embed

;

Save Embed

;

Kuangli Bio-Tech Holdings Co Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Kuangli Bio-Tech Holdings Co's Debt to Equity Ratio for the fiscal year that ended in Dec. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(197.103	+	139.72)	/	459.967
	=	0.73

Kuangli Bio-Tech Holdings Co's Debt to Equity Ratio for the quarter that ended in Mar. 2025 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(198.432	+	140.123)	/	755.689
	=	0.45

Kuangli Bio-Tech Holdings Co (TPE:6431) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Kuangli Bio-Tech Holdings Co Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Kuangli Bio-Tech Holdings Co's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Kuangli Bio-Tech Holdings Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Technology » Hardware » Kuangli Bio-Tech Holdings Co Ltd (TPE:6431) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

Jianguo North Road, 9th Floor, No. 66, Section. 2, Zhongshan District, Taipei, TWN, 10485

Website

https://www.kl-holdings.com

Kuangli Bio-Tech Holdings Co Ltd is mainly engaged in the manufacture and trading of various types of panels (LENS), such as mobile phone panels, digital camera windows, PDA panels, and instrument panels. The company is also engaged in the development, manufacturing and trading of cosmetics and skin care products and other related biotechnology products. It derives revenue from Health and Wellness products, and Cosmetics and skin care products, including Lotion, Facial masks, and Other pastes. The primary source of revenue for the company is sales of cosmetic products.

Kuangli Bio-Tech Holdings Co Headlines

No Headlines